ROCKVILLE CENTRE, N.Y., Jan. 9, 2019 /PRNewswire-PRWeb/ -- The Ken Pribil Jr. Foundation recently made its fifth annual
"We are proud to support angiosarcoma cancer research at MSK," said Kevin Pribil, President of the Board of Directors of the Ken Pribil Jr. Foundation. "It's a rare disease that is near and dear to our hearts, and we hope to continue this relationship and make a difference in people's lives."
This 2018 Ken Pribil Jr. Sarcoma Cancer Research Grant supports the research of Cristina R. Antonescu, MD, Director of MSK's Bone and Soft Tissue Pathology Service and one of the leading experts in angiosarcoma, a sarcoma subtype that forms in the inner lining of blood vessels. Her research is focused on the molecular mechanisms driving these tumors, how and why resistance begins, and genetic underpinnings that can be used to target angiosarcomas.
Since its inception in 2006, the Ken Pribil Jr. Foundation has given research grants to benefit sarcoma research at various institutions, including the Children's Hospital at Montefiore (CHAM) in the Bronx, NY, for the past three years. The Foundation has also supported business-focused undergraduate study with college scholarships to 17 graduating students from South Side High School in Rockville Centre, NY.
The Ken Pribil Jr. Foundation is a 501c3 tax-exempt nonprofit organization operating in New York State. To learn more, visit: http://www.kenpribiljr.org/
SOURCE Ken Pribil Jr. Foundation
Subscribe to our Free Newsletters!